Lifevantage Corp
LFVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000849146
In the last 90 days, Lifevantage Corp insiders filed 1 open-market purchase and 1 sale; 88 institutions reported holding it in 13F filings for Q2 2026, worth $36.9M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Lifevantage Corp as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 107
- −4 vs. Q2 2025
- Shares held
- 7.34M
- −38.9K (−0.5%) vs. Q2 2025
- Total value
- $71.3M
- −$25.1M (−26.1%) vs. Q2 2025
- New holders
- 12
- 35 more added
- Sold out
- 16
- 33 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LFVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 88 | $36.9M |
| Q1 2026 | 104 | $32.8M |
| Q4 2025 | 111 | $46.8M |
| Q3 2025 | 107 | $71.3M |
| Q2 2025 | 112 | $96.5M |
| Q1 2025 | 106 | $93.9M |
| Q4 2024 | 78 | $72.9M |
| Q3 2024 | 69 | $45.7M |
| Q2 2024 | 56 | $19.2M |
| Q1 2024 | 52 | $17.8M |
| Q4 2023 | 53 | $17.5M |
| Q3 2023 | 53 | $19.4M |
| Q2 2023 | 48 | $13.0M |
| Q1 2023 | 44 | $10.3M |
| Q4 2022 | 44 | $11.0M |
| Q3 2022 | 48 | $11.6M |
| Q2 2022 | 49 | $14.9M |
| Q1 2022 | 49 | $17.2M |
| Q4 2021 | 51 | $23.9M |
| Q3 2021 | 60 | $29.7M |
| Q2 2021 | 76 | $39.5M |
| Q1 2021 | 83 | $65.7M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Lifevantage Corp; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 242,688 | $2.36M | 0.00% | −48,817−16.7% | Reduced |
| Geode Capital Management, LLC | 243,581 | $2.37M | 0.00% | −1,751−0.7% | Reduced |
| Dimensional Fund Advisors LP | 292,566 | $2.85M | 0.00% | −343−0.1% | Reduced |
| Vanguard Group Inc | 561,109 | $5.46M | 0.00% | −3,264−0.6% | Reduced |
| BlackRock, Inc. | 748,832 | $7.29M | 0.00% | +149,092+24.9% | Added |
| Renaissance Technologies LLC | 852,018 | $8.29M | 0.01% | −42,400−4.7% | Reduced |
| Capital Management Corp | 2,064,176 | $20.1M | 3.16% | +798,066+63.0% | Added |
| Wasatch Advisors Inc | 0 | $0 | 0.00% | −446,341−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −70,977−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −53,098−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −45,791−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −45,662−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −32,637−100.0% | Sold out |
| Brown Advisory Inc | 0 | $0 | 0.00% | −10,301−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −7,200−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −6,575−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −4,914−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −2,109−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −1,780−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −497−100.0% | Sold out |
| Ameritas Advisory Services, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Beacon Capital Management, LLC | 0 | $0 | 0.00% | −176−100.0% | Sold out |
| Financial Gravity Companies, Inc. | – | – | – | – | Not filed |